The Role of Dead Space Syringes in HIV Epidemics Amount IDU's - Drug Abuse Aspect
死亡空间注射器在艾滋病毒流行中的作用 注射吸毒者数量 - 药物滥用方面
基本信息
- 批准号:7682792
- 负责人:
- 金额:$ 8.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAsiaBeliefBloodChinaCitiesCountryDataDrug abuseEastern EuropeEpidemicEpidemiologic StudiesEuropeGeneral PopulationHIVHIV InfectionsHepatitis CIncidence StudyIndiaIndividualInfectionInjecting drug userInjection of therapeutic agentInterventionInvestmentsKnowledgeLeadLinkLow PrevalenceModelingNeedle SharingOne-Step dentin bonding systemPlayPopulationPrevalenceProcessRecording of previous eventsResearch PersonnelResourcesRiskRoleRussiaSexual TransmissionSiteSyringesTestingTimeUnsafe SexViruscomparison groupexperiencehigh riskmathematical modelnovelprematurepublic health relevancetransmission process
项目摘要
DESCRIPTION (provided by applicant): HIV continues to spread among injecting drug users (IDUs) in many countries around the world. In recent years, cities in Eastern Europe, the Russian Federation, India, China, and other parts of Asia have experienced rapid increases in HIV prevalence among IDUs, while HIV prevalence has remained low and stable among IDUs in other cities despite high levels of injecting risk. Twenty-five years into the HIV epidemic among IDUs, researchers still do not really know why the virus spreads more in some places than others. Simple rates of syringe sharing and unprotected sex do not account for varying degrees of HIV transmission. One widely overlooked factor that could significantly contribute to these differences in HIV spread is the type of syringes that IDUs are using. The proposed study represents one step in the process of assessing the role of syringe type in HIV epidemics among IDUs. To date, we have established that it is biologically plausible that the type of syringe may play a role in HIV transmission by demonstrating that high dead-space syringes (HDSSs) retain over 1,000 times more blood after use and rinsing than low dead-space syringes (LDSSs) retain. We have linked a history of sharing HDSSs with prevalent HIV and HCV infection, and we have developed mathematical models that suggest injection-related HIV epidemics may not occur in cities, if fewer than 10% of IDUs are using HDSSs. The next step is to collect empirical data to test this finding. Large multisite longitudinal HIV incidence studies that collect data from individual IDUs on the types of syringes that they are using will be needed to establish a causal relationship between HDSSs and HIV infection among IDUs. However, these studies would require a considerable investment in time and money. Thus, we propose to conduct a small exploratory study to identify cities in Europe, Russia, and Asia where HIV prevalence among IDUs is high and cities where HIV prevalence among IDUs is low. We will seek to obtain information on the types of syringes that IDUs are using in these cities. The proposed study has the potential for yielding extremely valuable data for minimal investment. The specific aim of the proposed study is: To compare the types of syringes used by IDUs in cities where HIV prevalence among IDUs is high (>30%) or increasing (>5% per year for >3 years) with the types of syringes that IDUs are using in a matched comparison group of cities with low and stable HIV prevalence (<5% for >5 years). Should we find an ecological association between use of HDSSs and HIV prevalence, we will propose larger studies with the purpose of better delineating causal inference, including the role for sexual transmission.
PUBLIC HEALTH RELEVANCE: The information obtained in this project may substantially increase our knowledge of HIV transmission among injecting drug users (IDUs). If we find that the types of syringes used by IDUs influence HIV transmission, this could lead to relatively straightforward interventions that could substantially reduce HIV transmission in this high risk group. This in turn could reduce sexual transmission of HIV from IDUs to the general population.
描述(由申请人提供):艾滋病毒继续在世界许多国家的注射吸毒者 (IDU) 中传播。近年来,东欧、俄罗斯联邦、印度、中国和亚洲其他地区的城市注射吸毒者中艾滋病毒感染率迅速上升,而其他城市的注射吸毒者中艾滋病毒感染率尽管注射水平较高,但仍保持较低水平并保持稳定。风险。艾滋病毒在注射吸毒者中流行已经二十五年了,研究人员仍然不知道为什么这种病毒在某些地方比其他地方传播得更多。简单的共用注射器率和无保护性行为并不能解释不同程度的艾滋病毒传播。注射吸毒者使用的注射器类型是导致艾滋病毒传播差异的一个被广泛忽视的因素。拟议的研究代表了评估注射器类型在注射吸毒者中艾滋病毒流行中的作用过程中的一个步骤。迄今为止,我们通过证明高死腔注射器 (HDSS) 在使用和冲洗后保留的血液比低死腔注射器多 1,000 倍,证明注射器类型可能在 HIV 传播中发挥作用,这在生物学上是合理的(LDSS)保留。我们将共享 HDSS 的历史与流行的 HIV 和 HCV 感染联系起来,并且我们开发了数学模型,表明如果少于 10% 的注射吸毒者使用 HDSS,城市中可能不会发生与注射相关的 HIV 流行。下一步是收集经验数据来检验这一发现。需要开展大型多地点纵向艾滋病毒发病率研究,收集个体注射吸毒者所使用注射器类型的数据,以建立 HDSS 与注射吸毒者中艾滋病毒感染之间的因果关系。然而,这些研究需要投入大量的时间和金钱。因此,我们建议进行一项小型探索性研究,以确定欧洲、俄罗斯和亚洲注射吸毒者中艾滋病毒感染率较高的城市和注射吸毒者中艾滋病毒感染率较低的城市。我们将寻求获取有关这些城市注射吸毒者使用的注射器类型的信息。拟议的研究有可能以最少的投资产生极其有价值的数据。拟议研究的具体目的是: 比较注射吸毒者中艾滋病毒感染率较高(>30%)或呈上升趋势(>3 年每年>5%)的城市中注射吸毒者使用的注射器类型与注射器类型注射吸毒者在 HIV 感染率低且稳定的城市(>5 年 <5%)的匹配比较组中使用该数据。如果我们发现 HDSS 的使用与艾滋病毒流行之间存在生态关联,我们将提出更大规模的研究,以更好地描述因果推论,包括性传播的作用。
公共卫生相关性:本项目中获得的信息可能会大大增加我们对注射吸毒者 (IDU) 中艾滋病毒传播的了解。如果我们发现注射吸毒者使用的注射器类型会影响艾滋病毒的传播,那么可能会采取相对简单的干预措施,从而大大减少这一高危人群中艾滋病毒的传播。这反过来又可以减少艾滋病毒从注射吸毒者向普通人群的性传播。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM A ZULE其他文献
WILLIAM A ZULE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM A ZULE', 18)}}的其他基金
Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern Appalachia
减轻阿巴拉契亚南部注射吸毒流行病的相关后果
- 批准号:
10242157 - 财政年份:2017
- 资助金额:
$ 8.05万 - 项目类别:
Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern Appalachia
减轻阿巴拉契亚南部注射吸毒流行病的相关后果
- 批准号:
9760233 - 财政年份:2017
- 资助金额:
$ 8.05万 - 项目类别:
Pilot Test of an Intervention to Change Syringes Used by Injecting Drug Users
注射吸毒者更换注射器干预措施的试点试验
- 批准号:
8601366 - 财政年份:2013
- 资助金额:
$ 8.05万 - 项目类别:
Pilot Test of an Intervention to Change Syringes Used by Injecting Drug Users
注射吸毒者更换注射器干预措施的试点试验
- 批准号:
8719075 - 财政年份:2013
- 资助金额:
$ 8.05万 - 项目类别:
A Tailored Cue-Card Driven HIV/STI Intervention for High Risk Groups Pilot Study
针对高危人群的定制提示卡驱动的 HIV/STI 干预试点研究
- 批准号:
7684928 - 财政年份:2009
- 资助金额:
$ 8.05万 - 项目类别:
The Role of Dead Space Syringes in HIV Epidemics Amount IDU's - Drug Abuse Aspect
死亡空间注射器在艾滋病毒流行中的作用 注射吸毒者数量 - 药物滥用方面
- 批准号:
7776908 - 财政年份:2009
- 资助金额:
$ 8.05万 - 项目类别:
Motivating Changes in Condom, Methamphetamine Use During MSM Sexual Encounters
促使男男性行为者发生性行为时使用安全套和甲基苯丙胺的变化
- 批准号:
7223109 - 财政年份:2006
- 资助金额:
$ 8.05万 - 项目类别:
Motivating Changes in Condom, Methamphetamine Use During MSM Sexual Encounters
促使男男性行为者发生性行为时使用安全套和甲基苯丙胺的变化
- 批准号:
7494566 - 财政年份:2006
- 资助金额:
$ 8.05万 - 项目类别:
Modeling HIV Diffusion through Drug Using Networks
模拟艾滋病毒通过吸毒网络的传播
- 批准号:
7254775 - 财政年份:2003
- 资助金额:
$ 8.05万 - 项目类别:
Modeling HIV Diffusion through Drug Using Networks
模拟艾滋病毒通过吸毒网络的传播
- 批准号:
7070548 - 财政年份:2003
- 资助金额:
$ 8.05万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors
幸存者中药物引起的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症相关的遗传风险和长期结果
- 批准号:
10214660 - 财政年份:2019
- 资助金额:
$ 8.05万 - 项目类别:
Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors
幸存者中药物引起的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症相关的遗传风险和长期结果
- 批准号:
10441271 - 财政年份:2019
- 资助金额:
$ 8.05万 - 项目类别:
Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors
幸存者中药物引起的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症相关的遗传风险和长期结果
- 批准号:
10018069 - 财政年份:2019
- 资助金额:
$ 8.05万 - 项目类别:
Low-cost Mobile Oral Cancer Screening for Low Resource Setting
资源匮乏的低成本移动口腔癌筛查
- 批准号:
9762395 - 财政年份:2018
- 资助金额:
$ 8.05万 - 项目类别:
Low-cost Mobile Oral Cancer Screening for Low Resource Setting
资源匮乏的低成本移动口腔癌筛查
- 批准号:
9788365 - 财政年份:2018
- 资助金额:
$ 8.05万 - 项目类别: